A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.

MLA

Ramos, Louise, et al. “A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 29, no. 17, Sept. 2023, pp. 3541–53. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-22-3897.

APA

Ramos, L., Truong, S., Zhai, B., Joshi, J., Ghaidi, F., Lizardo, M. M., Shyp, T., Kung, S. H. Y., Rezakhanlou, A. M., Oo, H. Z., Adomat, H., Le Bihan, S., Collins, C., Bacha, J., Brown, D., Langlands, J., Shen, W., Lallous, N., Sorensen, P. H., & Daugaard, M. (2023). A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 29(17), 3541–3553. https://doi.org/10.1158/1078-0432.CCR-22-3897

Chicago

Ramos, Louise, Sarah Truong, Beibei Zhai, Jay Joshi, Fariba Ghaidi, Michael M Lizardo, Taras Shyp, et al. 2023. “A Bifunctional PARP-HDAC Inhibitor with Activity in Ewing Sarcoma.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 29 (17): 3541–53. doi:10.1158/1078-0432.CCR-22-3897.